PetMed Express, Inc.
PETS
$1.77
-$0.02-1.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 179.02M | 186.96M | 198.27M | 211.95M | 226.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 179.02M | 186.96M | 198.27M | 211.95M | 226.97M |
| Cost of Revenue | 128.81M | 135.49M | 140.12M | 147.44M | 157.84M |
| Gross Profit | 50.22M | 51.47M | 58.15M | 64.50M | 69.14M |
| SG&A Expenses | 69.22M | 80.28M | 77.55M | 76.51M | 70.39M |
| Depreciation & Amortization | 9.39M | 9.03M | 8.22M | 7.60M | 7.04M |
| Other Operating Expenses | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Operating Expenses | 207.41M | 224.81M | 225.89M | 231.55M | 235.26M |
| Operating Income | -28.39M | -37.84M | -27.62M | -19.61M | -8.29M |
| Income Before Tax | -57.36M | -59.18M | -48.88M | -39.44M | -587.00K |
| Income Tax Expenses | -73.00K | 5.69M | 6.15M | 4.74M | 5.68M |
| Earnings from Continuing Operations | -57.29 | -64.87 | -55.02 | -44.18 | -6.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.29M | -64.87M | -55.02M | -44.18M | -6.27M |
| EBIT | -28.39M | -37.84M | -27.62M | -19.61M | -8.29M |
| EBITDA | -19.00M | -28.81M | -19.40M | -12.00M | -1.25M |
| EPS Basic | -2.75 | -3.12 | -2.65 | -2.13 | -0.30 |
| Normalized Basic EPS | -0.81 | -1.14 | -0.83 | -0.57 | -0.22 |
| EPS Diluted | -2.76 | -3.13 | -2.66 | -2.14 | -0.31 |
| Normalized Diluted EPS | -0.81 | -1.14 | -0.83 | -0.57 | -0.23 |
| Average Basic Shares Outstanding | 83.69M | 83.29M | 82.92M | 82.63M | 82.38M |
| Average Diluted Shares Outstanding | 83.69M | 83.29M | 82.92M | 82.97M | 83.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.04% | -0.04% | -0.05% | -0.18% | -2.89% |